Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEVER-SLE: CD19-directed CAR-T for Refractory Systemic Lupus Erythematosus
NCT07659704Phase 2Not yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD19-directed CAR-T cells in systemic lupus erythematosus (SLE), sponsored by Universidade de São Paulo. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
autologous CD19-directed CAR-T cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07659704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07659704.